Abstract
The value and necessity of engaging patients during the development and lifecycle of medicines is increasingly recognised and many discrete initiatives are underway or planned.
Though complementary, these separate activities have resulted in a fragmented patient engagement (PE) landscape. Investment in a holistic, integrated and sustainable initiative is required to cover the entire medicines lifecycle and to connect stakeholders across geographies.
This poster focuses on the development of the PE Quality Guidance and identification of good practice examples.
Though complementary, these separate activities have resulted in a fragmented patient engagement (PE) landscape. Investment in a holistic, integrated and sustainable initiative is required to cover the entire medicines lifecycle and to connect stakeholders across geographies.
This poster focuses on the development of the PE Quality Guidance and identification of good practice examples.
Originalsprog | Engelsk |
---|---|
Publikationsdato | 2018 |
Antal sider | 1 |
Status | Udgivet - 2018 |
Begivenhed | ISPOR 2018 - , Spanien Varighed: 10 nov. 2018 → 14 nov. 2018 https://www.ispor.org/Event/index/2018barcelona |
Konference
Konference | ISPOR 2018 |
---|---|
Land/Område | Spanien |
Periode | 10/11/2018 → 14/11/2018 |
Internetadresse |